| Year |
Citation |
Score |
| 2024 |
Ronaldson PT, Davis TP. Blood-brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics. Expert Opinion On Drug Delivery. PMID 38217410 DOI: 10.1080/17425247.2024.2306138 |
0.732 |
|
| 2023 |
Ronaldson PT, Williams EI, Betterton RD, Stanton JA, Nilles KL, Davis TP. CNS Drug Delivery in Stroke: Improving Therapeutic Translation From the Bench to the Bedside. Stroke. 55: 190-202. PMID 38134249 DOI: 10.1161/STROKEAHA.123.043764 |
0.799 |
|
| 2023 |
Williams EI, Betterton RD, Stanton JA, Moreno-Rodriguez VM, Lochhead JJ, Davis TP, Ronaldson PT. Oatp (Organic Anion Transporting Polypeptide)-Mediated Transport: A Mechanism for Atorvastatin Neuroprotection in Stroke. Stroke. 54: 2875-2885. PMID 37750296 DOI: 10.1161/STROKEAHA.123.043649 |
0.799 |
|
| 2023 |
Forgham H, Liu L, Zhu J, Javed I, Cai W, Qiao R, Davis TP. Vector enabled CRISPR gene editing - A revolutionary strategy for targeting the diversity of brain pathologies. Coordination Chemistry Reviews. 487. PMID 37305445 DOI: 10.1016/j.ccr.2023.215172 |
0.319 |
|
| 2023 |
Lochhead JJ, Williams EI, Reddell ES, Dorn E, Ronaldson PT, Davis TP. High Resolution Multiplex Confocal Imaging of the Neurovascular Unit in Health and Experimental Ischemic Stroke. Cells. 12. PMID 36831312 DOI: 10.3390/cells12040645 |
0.795 |
|
| 2023 |
Betterton RD, Williams EI, Nilles KL, Davis TP, Ronaldson PT. Methods to Study Drug Uptake at the Blood-Brain Barrier Following Experimental Ischemic Stroke: In Vitro and In Vivo Approaches. Methods in Molecular Biology (Clifton, N.J.). 2616: 403-418. PMID 36715949 DOI: 10.1007/978-1-0716-2926-0_28 |
0.816 |
|
| 2022 |
Stanton JA, Williams EI, Betterton RD, Davis TP, Ronaldson PT. Targeting organic cation transporters at the blood-brain barrier to treat ischemic stroke in rats. Experimental Neurology. 357: 114181. PMID 35905840 DOI: 10.1016/j.expneurol.2022.114181 |
0.719 |
|
| 2022 |
Ronaldson PT, Davis TP. Transport Mechanisms at the Blood-Brain Barrier and in Cellular Compartments of the Neurovascular Unit: Focus on CNS Delivery of Small Molecule Drugs. Pharmaceutics. 14. PMID 35890396 DOI: 10.3390/pharmaceutics14071501 |
0.715 |
|
| 2022 |
Yang J, Betterton RD, Williams EI, Stanton JA, Reddell ES, Ogbonnaya CE, Dorn E, Davis TP, Lochhead JJ, Ronaldson PT. High-Dose Acetaminophen Alters the Integrity of the Blood-Brain Barrier and Leads to Increased CNS Uptake of Codeine in Rats. Pharmaceutics. 14. PMID 35631535 DOI: 10.3390/pharmaceutics14050949 |
0.82 |
|
| 2022 |
Betterton RD, Abdullahi W, Williams EI, Lochhead JL, Brzica H, Stanton JA, Reddell E, Ogbonnaya C, Davis TP, Ronaldson PT. . Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 35504656 DOI: 10.1124/dmd.121.000781 |
0.727 |
|
| 2022 |
Nilles KL, Williams EI, Betterton RD, Davis TP, Ronaldson PT. Blood-Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke. International Journal of Molecular Sciences. 23. PMID 35163820 DOI: 10.3390/ijms23031898 |
0.805 |
|
| 2021 |
Betterton RD, Davis TP, Ronaldson PT. Organic Cation Transporter (OCT/OCTN) Expression at Brain Barrier Sites: Focus on CNS Drug Delivery. Handbook of Experimental Pharmacology. PMID 33674914 DOI: 10.1007/164_2021_448 |
0.733 |
|
| 2020 |
Ronaldson PT, Brzica H, Abdullahi W, Reilly BG, Davis TP. . The Journal of Pharmacology and Experimental Therapeutics. PMID 33168642 DOI: 10.1124/jpet.120.000267 |
0.669 |
|
| 2020 |
Ronaldson PT, Davis TP. Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X20951995. PMID 32928017 DOI: 10.1177/0271678X20951995 |
0.722 |
|
| 2020 |
Lochhead JJ, Yang J, Ronaldson PT, Davis TP. Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders. Frontiers in Physiology. 11: 914. PMID 32848858 DOI: 10.3389/Fphys.2020.00914 |
0.828 |
|
| 2020 |
Mukherjee P, Lyden P, Fernández JA, Davis TP, Pryor KE, Zlokovic BV, Griffin JH. 3K3A-Activated Protein C Variant Does Not Interfere With the Plasma Clot Lysis Activity of Tenecteplase. Stroke. 51: 2236-2239. PMID 32568648 DOI: 10.1161/Strokeaha.120.028793 |
0.31 |
|
| 2020 |
Liktor-Busa E, Blawn KT, Kellohen KL, Wiese BM, Verkhovsky V, Wahl J, Vivek A, Palomino SM, Davis TP, Vanderah TW, Largent-Milnes TM. Functional NHE1 expression is critical to blood brain barrier integrity and sumatriptan blood to brain uptake. Plos One. 15: e0227463. PMID 32469979 DOI: 10.1371/Journal.Pone.0227463 |
0.685 |
|
| 2020 |
Williams EI, Betterton RD, Davis TP, Ronaldson PT. Transporter-Mediated Delivery of Small Molecule Drugs to the Brain: A Critical Mechanism That Can Advance Therapeutic Development for Ischemic Stroke. Pharmaceutics. 12. PMID 32075088 DOI: 10.3390/pharmaceutics12020154 |
0.711 |
|
| 2019 |
Lochhead JJ, Davis TP. Perivascular and Perineural Pathways Involved in Brain Delivery and Distribution of Drugs after Intranasal Administration. Pharmaceutics. 11. PMID 31726721 DOI: 10.3390/Pharmaceutics11110598 |
0.741 |
|
| 2019 |
Lochhead JJ, Kellohen KL, Ronaldson PT, Davis TP. Distribution of insulin in trigeminal nerve and brain after intranasal administration. Scientific Reports. 9: 2621. PMID 30796294 DOI: 10.1038/S41598-019-39191-5 |
0.77 |
|
| 2018 |
Tome ME, Jarvis CK, Schaefer CP, Jacobs LM, Herndon JM, Hunn KC, Arkwright NB, Kellohen KL, Mierau PC, Davis TP. Acute pain alters P-glycoprotein-containing protein complexes in rat cerebral microvessels: Implications for P-glycoprotein trafficking. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X18803623. PMID 30346224 DOI: 10.1177/0271678X18803623 |
0.39 |
|
| 2018 |
Yang J, Reilly BG, Davis TP, Ronaldson PT. Modulation of Opioid Transport at the Blood-Brain Barrier by Altered ATP-Binding Cassette (ABC) Transporter Expression and Activity. Pharmaceutics. 10. PMID 30340346 DOI: 10.3390/pharmaceutics10040192 |
0.703 |
|
| 2018 |
Cottier KE, Galloway EA, Calabrese EC, Tome ME, Liktor-Busa E, Kim J, Davis TP, Vanderah TW, Largent-Milnes TM. Loss of Blood-Brain Barrier Integrity in a KCl-Induced Model of Episodic Headache Enhances CNS Drug Delivery. Eneuro. 5. PMID 30073201 DOI: 10.1523/ENEURO.0116-18.2018 |
0.642 |
|
| 2018 |
Schaefer CP, Arkwright NB, Jacobs LM, Jarvis CK, Hunn KC, Largent-Milnes TM, Tome ME, Davis TP. Chronic morphine exposure potentiates p-glycoprotein trafficking from nuclear reservoirs in cortical rat brain microvessels. Plos One. 13: e0192340. PMID 29414996 DOI: 10.1371/Journal.Pone.0192340 |
0.361 |
|
| 2017 |
Sandweiss AJ, Cottier KE, McIntosh MI, Dussor G, Davis TP, Vanderah TW, Largent-Milnes TM. 17-β-Estradiol induces spreading depression and pain behavior in alert female rats. Oncotarget. 8: 114109-114122. PMID 29371973 DOI: 10.18632/Oncotarget.23141 |
0.507 |
|
| 2017 |
Schaefer CP, Tome ME, Davis TP. The opioid epidemic: a central role for the blood brain barrier in opioid analgesia and abuse. Fluids and Barriers of the Cns. 14: 32. PMID 29183383 DOI: 10.1186/s12987-017-0080-3 |
0.387 |
|
| 2017 |
Abdullahi W, Davis TP, Ronaldson PT. Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery? The Aaps Journal. PMID 28447295 DOI: 10.1208/s12248-017-0081-9 |
0.735 |
|
| 2017 |
Abdullahi W, Brzica H, Ibbotson K, Davis TP, Ronaldson PT. Bone morphogenetic protein-9 increases the functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier via the activin receptor-like kinase-1 receptor. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X17702916. PMID 28387157 DOI: 10.1177/0271678X17702916 |
0.749 |
|
| 2017 |
Lochhead JJ, Ronaldson PT, Davis TP. Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System. The Aaps Journal. PMID 28353217 DOI: 10.1208/S12248-017-0076-6 |
0.836 |
|
| 2017 |
Cottier K, Galoway E, Kim J, Vanderah T, Davis T, Largent-Milnes T. (143) Transient Decreases in Blood-Brain Barrier Integrity Correspond with Facial Allodynia Duration in a Model of Migraine with Aura The Journal of Pain. 18: S12. DOI: 10.1016/J.Jpain.2017.02.049 |
0.655 |
|
| 2017 |
Ronaldson PT, Davis TP. Mechanisms of Endothelial Injury and Blood–Brain Barrier Dysfunction in Stroke Primer On Cerebrovascular Diseases. 220-226. DOI: 10.1016/B978-0-12-803058-5.00045-X |
0.727 |
|
| 2017 |
Herndon JM, Tome ME, Davis TP. Development and Maintenance of the Blood–Brain Barrier Primer On Cerebrovascular Diseases. 51-56. DOI: 10.1016/B978-0-12-803058-5.00009-6 |
0.434 |
|
| 2016 |
Tome ME, Herndon JM, Schaefer CP, Jacobs LM, Zhang Y, Jarvis CK, Davis TP. P-glycoprotein traffics from the nucleus to the plasma membrane in rat brain endothelium during inflammatory pain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 27466374 DOI: 10.1177/0271678X16661728 |
0.446 |
|
| 2015 |
Davis TP, Abbruscato TJ, Egleton RD. Peptides at the blood brain barrier: Knowing me knowing you. Peptides. PMID 25937599 DOI: 10.1016/j.peptides.2015.04.020 |
0.799 |
|
| 2015 |
Tome ME, Schaefer CP, Jacobs LM, Zhang Y, Herndon JM, Matty FO, Davis TP. Identification of P-glycoprotein co-fractionating proteins and specific binding partners in rat brain microvessels. Journal of Neurochemistry. 134: 200-210. PMID 25832806 DOI: 10.1111/Jnc.13106 |
0.492 |
|
| 2015 |
Ronaldson PT, Davis TP. Targeting transporters: Promoting blood-brain barrier repair in response to oxidative stress injury. Brain Research. PMID 25796436 DOI: 10.1016/j.brainres.2015.03.018 |
0.742 |
|
| 2014 |
Davis TP, Sanchez-Covarubias L, Tome ME. P-glycoprotein trafficking as a therapeutic target to optimize CNS drug delivery. Advances in Pharmacology (San Diego, Calif.). 71: 25-44. PMID 25307213 DOI: 10.1016/bs.apha.2014.06.009 |
0.416 |
|
| 2014 |
Sanchez-Covarrubias L, Slosky LM, Thompson BJ, Zhang Y, Laracuente ML, DeMarco KM, Ronaldson PT, Davis TP. P-glycoprotein modulates morphine uptake into the CNS: a role for the non-steroidal anti-inflammatory drug diclofenac. Plos One. 9: e88516. PMID 24520393 DOI: 10.1371/Journal.Pone.0088516 |
0.723 |
|
| 2014 |
Sanchez-Covarrubias L, Slosky LM, Thompson BJ, Davis TP, Ronaldson PT. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery? Current Pharmaceutical Design. 20: 1422-49. PMID 23789948 DOI: 10.2174/13816128113199990463 |
0.716 |
|
| 2013 |
Ronaldson PT, Davis TP. Gabapentin and diclofenac reduce opioid consumption in patients undergoing tonsillectomy: a result of altered CNS drug delivery? Archives of Trauma Research. 2: 97-8. PMID 24396803 DOI: 10.5812/atr.11011 |
0.712 |
|
| 2013 |
Mosnier LO, Fernández JA, Davis TP, Zlokovic BV, Griffin JH. Influence of the 3K3A-activated protein C variant on the plasma clot lysis activity of t-PA and of t-PA on the variant's anticoagulant activity. Journal of Thrombosis and Haemostasis : Jth. 11: 2059-62. PMID 24034518 DOI: 10.1111/Jth.12400 |
0.311 |
|
| 2013 |
Slosky LM, Thompson BJ, Sanchez-Covarrubias L, Zhang Y, Laracuente ML, Vanderah TW, Ronaldson PT, Davis TP. Acetaminophen modulates P-glycoprotein functional expression at the blood-brain barrier by a constitutive androstane receptor-dependent mechanism. Molecular Pharmacology. 84: 774-86. PMID 24019224 DOI: 10.1124/Mol.113.086298 |
0.784 |
|
| 2013 |
Guo H, Zhao Z, Yang Q, Wang M, Bell RD, Wang S, Chow N, Davis TP, Griffin JH, Goldman SA, Zlokovic BV. An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 6181-90. PMID 23554499 DOI: 10.1523/Jneurosci.4491-12.2013 |
0.318 |
|
| 2013 |
Ronaldson PT, Davis TP. Targeted drug delivery to treat pain and cerebral hypoxia. Pharmacological Reviews. 65: 291-314. PMID 23343976 DOI: 10.1124/pr.112.005991 |
0.745 |
|
| 2013 |
Egleton RD, Witt KA, Davis TP. Opioid Peptides Handbook of Biologically Active Peptides. 1696-1701. DOI: 10.1016/B978-0-12-385095-9.00232-3 |
0.773 |
|
| 2012 |
McCaffrey G, Davis TP. Physiology and pathophysiology of the blood-brain barrier: P-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug delivery. Journal of Investigative Medicine : the Official Publication of the American Federation For Clinical Research. 60: 1131-40. PMID 23138008 DOI: 10.231/JIM.0b013e318276de79 |
0.487 |
|
| 2012 |
McCaffrey G, Staatz WD, Sanchez-Covarrubias L, Finch JD, Demarco K, Laracuente ML, Ronaldson PT, Davis TP. P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia. Journal of Neurochemistry. 122: 962-75. PMID 22716933 DOI: 10.1111/j.1471-4159.2012.07831.x |
0.715 |
|
| 2012 |
Williams PD, Zlokovic BV, Griffin JH, Pryor KE, Davis TP. Preclinical safety and pharmacokinetic profile of 3K3A-APC, a novel, modified activated protein C for ischemic stroke. Current Pharmaceutical Design. 18: 4215-22. PMID 22632606 DOI: 10.2174/138161212802430413 |
0.303 |
|
| 2012 |
Ronaldson PT, Davis TP. Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke. Current Pharmaceutical Design. 18: 3624-44. PMID 22574987 DOI: 10.2174/138161212802002625 |
0.744 |
|
| 2012 |
Lochhead JJ, McCaffrey G, Sanchez-Covarrubias L, Finch JD, Demarco KM, Quigley CE, Davis TP, Ronaldson PT. Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain. American Journal of Physiology. Heart and Circulatory Physiology. 302: H582-93. PMID 22081706 DOI: 10.1152/Ajpheart.00889.2011 |
0.836 |
|
| 2011 |
Ronaldson PT, Davis TP. Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery. Therapeutic Delivery. 2: 1015-41. PMID 22468221 DOI: 10.4155/tde.11.67 |
0.736 |
|
| 2011 |
Ronaldson PT, Finch JD, Demarco KM, Quigley CE, Davis TP. Inflammatory pain signals an increase in functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier. The Journal of Pharmacology and Experimental Therapeutics. 336: 827-39. PMID 21131267 DOI: 10.1124/jpet.110.174151 |
0.738 |
|
| 2010 |
Willis CL, Meske DS, Davis TP. Protein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 30: 1847-59. PMID 20700133 DOI: 10.1038/jcbfm.2010.119 |
0.458 |
|
| 2010 |
Lochhead JJ, McCaffrey G, Quigley CE, Finch J, DeMarco KM, Nametz N, Davis TP. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 30: 1625-36. PMID 20234382 DOI: 10.1038/Jcbfm.2010.29 |
0.737 |
|
| 2010 |
Witt KA, Ronaldson PT, Sandoval KE, Davis TP. CNS delivery of peptides across the bbb using the dual-artery in situ brain perfusion model Neuromethods. 45: 233-247. DOI: 10.1007/978-1-60761-529-3_11 |
0.803 |
|
| 2009 |
McCaffrey G, Willis CL, Staatz WD, Nametz N, Quigley CA, Hom S, Lochhead JJ, Davis TP. Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. Journal of Neurochemistry. 110: 58-71. PMID 19457074 DOI: 10.1111/J.1471-4159.2009.06113.X |
0.79 |
|
| 2009 |
Ronaldson PT, Demarco KM, Sanchez-Covarrubias L, Solinsky CM, Davis TP. Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 29: 1084-98. PMID 19319146 DOI: 10.1038/jcbfm.2009.32 |
0.696 |
|
| 2009 |
Wang Y, Thiyagarajan M, Chow N, Singh I, Guo H, Davis TP, Zlokovic BV. Differential neuroprotection and risk for bleeding from activated protein C with varying degrees of anticoagulant activity. Stroke; a Journal of Cerebral Circulation. 40: 1864-9. PMID 19057019 DOI: 10.1161/Strokeaha.108.536680 |
0.37 |
|
| 2008 |
Willis CL, Brooks TA, Davis TP. Chronic inflammatory pain and the neurovascular unit: a central role for glia in maintaining BBB integrity? Current Pharmaceutical Design. 14: 1625-43. PMID 18673205 DOI: 10.2174/138161208784705414 |
0.384 |
|
| 2008 |
McCaffrey G, Seelbach MJ, Staatz WD, Nametz N, Quigley C, Campos CR, Brooks TA, Davis TP. Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia. Journal of Neurochemistry. 106: 2395-409. PMID 18647175 DOI: 10.1111/J.1471-4159.2008.05582.X |
0.833 |
|
| 2008 |
Campos CR, Ocheltree SM, Hom S, Egleton RD, Davis TP. Nociceptive inhibition prevents inflammatory pain induced changes in the blood-brain barrier. Brain Research. 1221: 6-13. PMID 18554577 DOI: 10.1016/J.Brainres.2008.05.013 |
0.822 |
|
| 2008 |
Brooks TA, Nametz N, Charles R, Davis TP. Diclofenac attenuates the regional effect of lambda-carrageenan on blood-brain barrier function and cytoarchitecture. The Journal of Pharmacology and Experimental Therapeutics. 325: 665-73. PMID 18305016 DOI: 10.1124/Jpet.107.135632 |
0.426 |
|
| 2008 |
Neuwelt E, Abbott NJ, Abrey L, Banks WA, Blakley B, Davis T, Engelhardt B, Grammas P, Nedergaard M, Nutt J, Pardridge W, Rosenberg GA, Smith Q, Drewes LR. Strategies to advance translational research into brain barriers. The Lancet. Neurology. 7: 84-96. PMID 18093565 DOI: 10.1016/S1474-4422(07)70326-5 |
0.483 |
|
| 2008 |
Witt KA, Mark KS, Sandoval KE, Davis TP. Reoxygenation stress on blood-brain barrier paracellular permeability and edema in the rat. Microvascular Research. 75: 91-6. PMID 17651765 DOI: 10.1016/J.Mvr.2007.06.004 |
0.818 |
|
| 2007 |
McCaffrey G, Staatz WD, Quigley CA, Nametz N, Seelbach MJ, Campos CR, Brooks TA, Egleton RD, Davis TP. Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo. Journal of Neurochemistry. 103: 2540-55. PMID 17931362 DOI: 10.1111/J.1471-4159.2007.04943.X |
0.813 |
|
| 2007 |
Seelbach MJ, Brooks TA, Egleton RD, Davis TP. Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein. Journal of Neurochemistry. 102: 1677-90. PMID 17697052 DOI: 10.1111/J.1471-4159.2007.04644.X |
0.843 |
|
| 2007 |
Hom S, Fleegal MA, Egleton RD, Campos CR, Hawkins BT, Davis TP. Comparative changes in the blood-brain barrier and cerebral infarction of SHR and WKY rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 292: R1881-92. PMID 17234953 DOI: 10.1152/Ajpregu.00761.2005 |
0.815 |
|
| 2006 |
Brooks TA, Ocheltree SM, Seelbach MJ, Charles RA, Nametz N, Egleton RD, Davis TP. Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain. Brain Research. 1120: 172-82. PMID 17007822 DOI: 10.1016/J.Brainres.2006.08.085 |
0.832 |
|
| 2006 |
Witt KA, Davis TP. CNS drug delivery: opioid peptides and the blood-brain barrier. The Aaps Journal. 8: E76-88. PMID 16584136 DOI: 10.1208/Aapsj080109 |
0.693 |
|
| 2006 |
Huber JD, Campos CR, Mark KS, Davis TP. Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain. American Journal of Physiology. Heart and Circulatory Physiology. 290: H732-40. PMID 16199477 DOI: 10.1152/Ajpheart.00747.2005 |
0.841 |
|
| 2006 |
Egleton RD, Witt KA, Davis TP. Opiate Peptides And The Blood-Brain Barrier Handbook of Biologically Active Peptides. 1429-1434. DOI: 10.1016/B978-012369442-3/50202-6 |
0.833 |
|
| 2005 |
Fleegal MA, Hom S, Borg LK, Davis TP. Activation of PKC modulates blood-brain barrier endothelial cell permeability changes induced by hypoxia and posthypoxic reoxygenation. American Journal of Physiology. Heart and Circulatory Physiology. 289: H2012-9. PMID 15994856 DOI: 10.1152/Ajpheart.00495.2005 |
0.701 |
|
| 2005 |
Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacological Reviews. 57: 173-85. PMID 15914466 DOI: 10.1124/pr.57.2.4 |
0.839 |
|
| 2005 |
Brooks TA, Hawkins BT, Huber JD, Egleton RD, Davis TP. Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. American Journal of Physiology. Heart and Circulatory Physiology. 289: H738-43. PMID 15792985 DOI: 10.1152/Ajpheart.01288.2004 |
0.83 |
|
| 2005 |
Egleton RD, Davis TP. Development of neuropeptide drugs that cross the blood-brain barrier. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 2: 44-53. PMID 15717056 DOI: 10.1602/neurorx.2.1.44 |
0.822 |
|
| 2005 |
Hawkins BT, Egleton RD, Davis TP. Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors. American Journal of Physiology. Heart and Circulatory Physiology. 289: H212-9. PMID 15708958 DOI: 10.1152/ajpheart.01210.2004 |
0.814 |
|
| 2005 |
Doolittle ND, Abrey LE, Bleyer WA, Brem S, Davis TP, Dore-Duffy P, Drewes LR, Hall WA, Hoffman JM, Korfel A, Martuza R, Muldoon LL, Peereboom D, Peterson DR, Rabkin SD, et al. New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 421-8. PMID 15701824 |
0.392 |
|
| 2005 |
Brown RC, Davis TP. Hypoxia/aglycemia alters expression of occludin and actin in brain endothelial cells. Biochemical and Biophysical Research Communications. 327: 1114-23. PMID 15652512 DOI: 10.1016/j.bbrc.2004.12.123 |
0.431 |
|
| 2005 |
Witt KA, Mark KS, Huber J, Davis TP. Hypoxia-inducible factor and nuclear factor kappa-B activation in blood-brain barrier endothelium under hypoxic/reoxygenation stress. Journal of Neurochemistry. 92: 203-14. PMID 15606909 DOI: 10.1111/J.1471-4159.2004.02871.X |
0.798 |
|
| 2004 |
Hawkins BT, Abbruscato TJ, Egleton RD, Brown RC, Huber JD, Campos CR, Davis TP. Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Research. 1027: 48-58. PMID 15494156 DOI: 10.1016/J.Brainres.2004.08.043 |
0.816 |
|
| 2004 |
Landen JW, Hau V, Wang M, Davis T, Ciliax B, Wainer BH, Van Meir EG, Glass JD, Joshi HC, Archer DR. Noscapine crosses the blood-brain barrier and inhibits glioblastoma growth. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 5187-201. PMID 15297423 DOI: 10.1158/1078-0432.Ccr-04-0360 |
0.801 |
|
| 2004 |
Hau VS, Huber JD, Campos CR, Davis RT, Davis TP. Effect of lambda-carrageenan-induced inflammatory pain on brain uptake of codeine and antinociception. Brain Research. 1018: 257-64. PMID 15276886 DOI: 10.1016/J.Brainres.2004.05.081 |
0.837 |
|
| 2004 |
Brown RC, Egleton RD, Davis TP. Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin. Brain Research. 1014: 221-7. PMID 15213006 DOI: 10.1016/j.brainres.2004.04.034 |
0.836 |
|
| 2004 |
Brown RC, Mark KS, Egleton RD, Davis TP. Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium. American Journal of Physiology. Cell Physiology. 286: C1045-52. PMID 15075203 DOI: 10.1152/Ajpcell.00360.2003 |
0.791 |
|
| 2004 |
Mark KS, Burroughs AR, Brown RC, Huber JD, Davis TP. Nitric oxide mediates hypoxia-induced changes in paracellular permeability of cerebral microvasculature. American Journal of Physiology. Heart and Circulatory Physiology. 286: H174-80. PMID 12958038 DOI: 10.1152/Ajpheart.00669.2002 |
0.801 |
|
| 2003 |
Wolka AM, Huber JD, Davis TP. Pain and the blood-brain barrier: obstacles to drug delivery. Advanced Drug Delivery Reviews. 55: 987-1006. PMID 12935941 DOI: 10.1016/S0169-409X(03)00100-5 |
0.488 |
|
| 2003 |
Witt KA, Mark KS, Hom S, Davis TP. Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression. American Journal of Physiology. Heart and Circulatory Physiology. 285: H2820-31. PMID 12907427 DOI: 10.1152/Ajpheart.00589.2003 |
0.846 |
|
| 2003 |
Huber JD, Campos CR, Egleton RD, Witt K, Guo L, Roberts MJ, Bentley MD, Davis TP. Conjugation of low molecular weight poly(ethylene glycol) to biphalin enhances antinociceptive profile. Journal of Pharmaceutical Sciences. 92: 1377-85. PMID 12820142 DOI: 10.1002/Jps.10406 |
0.779 |
|
| 2003 |
Egleton RD, Campos CC, Huber JD, Brown RC, Davis TP. Differential effects of diabetes on rat choroid plexus ion transporter expression. Diabetes. 52: 1496-501. PMID 12765962 DOI: 10.2337/Diabetes.52.6.1496 |
0.776 |
|
| 2003 |
Brown RC, Mark KS, Egleton RD, Huber JD, Burroughs AR, Davis TP. Protection against hypoxia-induced increase in blood-brain barrier permeability: role of tight junction proteins and NFkappaB. Journal of Cell Science. 116: 693-700. PMID 12538770 DOI: 10.1242/Jcs.00264 |
0.819 |
|
| 2003 |
Egleton RD, Witt KA, Davis TP. Peptides and the Blood-Brain Barrier: Enhancing Peptide Bioavailability to the Brain Blood-Spinal Cord and Brain Barriers in Health and Disease. 107-115. DOI: 10.1016/B978-012639011-7/50015-2 |
0.829 |
|
| 2002 |
Abbruscato TJ, Lopez SP, Mark KS, Hawkins BT, Davis TP. Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells. Journal of Pharmaceutical Sciences. 91: 2525-38. PMID 12434396 DOI: 10.1002/Jps.10256 |
0.812 |
|
| 2002 |
Witt KA, Huber JD, Egleton RD, Davis TP. Pluronic p85 block copolymer enhances opioid peptide analgesia. The Journal of Pharmacology and Experimental Therapeutics. 303: 760-7. PMID 12388663 DOI: 10.1124/Jpet.102.039545 |
0.785 |
|
| 2002 |
Huber JD, Hau VS, Borg L, Campos CR, Egleton RD, Davis TP. Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain. American Journal of Physiology. Heart and Circulatory Physiology. 283: H1531-7. PMID 12234806 DOI: 10.1152/Ajpheart.00027.2002 |
0.833 |
|
| 2002 |
Hau VS, Huber JD, Campos CR, Lipkowski AW, Misicka A, Davis TP. Effect of guanidino modification and proline substitution on the in vitro stability and blood-brain barrier permeability of endomorphin II. Journal of Pharmaceutical Sciences. 91: 2140-9. PMID 12226841 DOI: 10.1002/Jps.10202 |
0.827 |
|
| 2002 |
Huber JD, Hau VS, Mark KS, Brown RC, Campos CR, Davis TP. Viability of microvascular endothelial cells to direct exposure of formalin, lambda-carrageenan, and complete Freund's adjuvant. European Journal of Pharmacology. 450: 297-304. PMID 12208323 DOI: 10.1016/S0014-2999(02)02150-7 |
0.834 |
|
| 2002 |
Brown RC, Davis TP. Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke. Stroke; a Journal of Cerebral Circulation. 33: 1706-11. PMID 12053015 DOI: 10.1161/01.STR.0000016405.06729.83 |
0.363 |
|
| 2002 |
Mark KS, Davis TP. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. American Journal of Physiology. Heart and Circulatory Physiology. 282: H1485-94. PMID 11893586 DOI: 10.1152/Ajpheart.00645.2001 |
0.804 |
|
| 2002 |
Hawkins BT, Brown RC, Davis TP. Smoking and ischemic stroke: a role for nicotine? Trends in Pharmacological Sciences. 23: 78-82. PMID 11830264 DOI: 10.1016/S0165-6147(02)01893-X |
0.776 |
|
| 2001 |
Witt KA, Gillespie TJ, Huber JD, Egleton RD, Davis TP. Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability. Peptides. 22: 2329-43. PMID 11786210 DOI: 10.1016/S0196-9781(01)00537-X |
0.82 |
|
| 2001 |
Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends in Neurosciences. 24: 719-25. PMID 11718877 DOI: 10.1016/S0166-2236(00)02004-X |
0.832 |
|
| 2001 |
Egleton RD, Mitchell SA, Huber JD, Palian MM, Polt R, Davis TP. Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation. The Journal of Pharmacology and Experimental Therapeutics. 299: 967-72. PMID 11714884 |
0.818 |
|
| 2001 |
Witt KA, Huber JD, Egleton RD, Roberts MJ, Bentley MD, Guo L, Wei H, Yamamura HI, Davis TP. Pharmacodynamic and pharmacokinetic characterization of poly(ethylene glycol) conjugation to met-enkephalin analog [D-Pen2, D-Pen5]-enkephalin (DPDPE). The Journal of Pharmacology and Experimental Therapeutics. 298: 848-56. PMID 11454951 |
0.818 |
|
| 2001 |
Huber JD, Witt KA, Hom S, Egleton RD, Mark KS, Davis TP. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. American Journal of Physiology. Heart and Circulatory Physiology. 280: H1241-8. PMID 11179069 DOI: 10.1152/Ajpheart.2001.280.3.H1241 |
0.826 |
|
| 2001 |
Hom S, Egleton RD, Huber JD, Davis TP. Effect of reduced flow on blood-brain barrier transport systems. Brain Research. 890: 38-48. PMID 11164767 DOI: 10.1016/S0006-8993(00)03027-4 |
0.814 |
|
| 2000 |
Mark KS, Davis TP. Stroke: development, prevention and treatment with peptidase inhibitors. Peptides. 21: 1965-73. PMID 11150655 DOI: 10.1016/S0196-9781(00)00346-6 |
0.729 |
|
| 2000 |
Witt KA, Huber JD, Egleton RD, Davis TP. Insulin enhancement of opioid peptide transport across the blood-brain barrier and assessment of analgesic effect. The Journal of Pharmacology and Experimental Therapeutics. 295: 972-8. PMID 11082431 |
0.809 |
|
| 2000 |
Egleton RD, Mitchell SA, Huber JD, Janders J, Stropova D, Polt R, Yamamura HI, Hruby VJ, Davis TP. Improved bioavailability to the brain of glycosylated Met-enkephalin analogs. Brain Research. 881: 37-46. PMID 11033091 DOI: 10.1016/S0006-8993(00)02794-3 |
0.824 |
|
| 2000 |
Bilsky EJ, Egleton RD, Mitchell SA, Palian MM, Davis P, Huber JD, Jones H, Yamamura HI, Janders J, Davis TP, Porreca F, Hruby VJ, Polt R. Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability. Journal of Medicinal Chemistry. 43: 2586-90. PMID 10891118 DOI: 10.1021/Jm000077Y |
0.83 |
|
| 2000 |
Witt KA, Slate CA, Egleton RD, Huber JD, Yamamura HI, Hruby VJ, Davis TP. Assessment of stereoselectivity of trimethylphenylalanine analogues of delta-opioid [D-Pen(2),D-Pen(5)]-enkephalin. Journal of Neurochemistry. 75: 424-35. PMID 10854288 DOI: 10.1046/J.1471-4159.2000.0750424.X |
0.79 |
|
| 2000 |
Newcomb R, Abbruscato TJ, Singh T, Nadasdi L, Davis TP, Miljanich G. Bioavailability of Ziconotide in brain: influx from blood, stability, and diffusion. Peptides. 21: 491-501. PMID 10822104 DOI: 10.1016/S0196-9781(00)00175-3 |
0.489 |
|
| 1999 |
Gentry CL, Egleton RD, Gillespie T, Abbruscato TJ, Bechowski HB, Hruby VJ, Davis TP. The effect of halogenation on blood-brain barrier permeability of a novel peptide drug. Peptides. 20: 1229-38. PMID 10573295 DOI: 10.1016/S0196-9781(99)00127-8 |
0.835 |
|
| 1999 |
Abbruscato TJ, Davis TP. Protein expression of brain endothelial cell E-cadherin after hypoxia/aglycemia: influence of astrocyte contact. Brain Research. 842: 277-86. PMID 10526124 DOI: 10.1016/S0006-8993(99)01778-3 |
0.468 |
|
| 1999 |
Abbruscato TJ, Davis TP. Combination of hypoxia/aglycemia compromises in vitro blood-brain barrier integrity. The Journal of Pharmacology and Experimental Therapeutics. 289: 668-75. PMID 10215638 |
0.339 |
|
| 1999 |
Egleton RD, Davis TP. Transport of the delta-opioid receptor agonist [D-penicillamine2,5] enkephalin across the blood-brain barrier involves transcytosis1. Journal of Pharmaceutical Sciences. 88: 392-7. PMID 10187748 DOI: 10.1021/js980410+ |
0.84 |
|
| 1999 |
Hau VS, Campos C, Hoshata K, Lipokowski A, Yamamura HI, Hruby VJ, Davis TP. Guanidino cationization effects on the blood-brain barrier permeability, in vitro stability and receptor binding of endomorphins Journal of Investigative Medicine. 47: 34A. |
0.792 |
|
| 1998 |
Kline JP, Bell I, Schwartz GE, Hau V, Davis T. Repressive and defensive coping styles predict resting plasma endorphin levels in the elderly. Biological Psychology. 49: 295-302. PMID 9858058 DOI: 10.1016/S0301-0511(98)00048-9 |
0.744 |
|
| 1998 |
Egleton RD, Abbruscato TJ, Thomas SA, Davis TP. Transport of opioid peptides into the central nervous system. Journal of Pharmaceutical Sciences. 87: 1433-9. PMID 9811502 DOI: 10.1021/js980062b |
0.813 |
|
| 1998 |
Slaninova J, Appleyard SM, Misicka A, Lipkowski AW, Knapp RJ, Weber SJ, Davis TP, Yamamura HI, Hruby VJ. [125I-Tyr1]biphalin binding to opioid receptors of rat brain and NG108-15 cell membranes. Life Sciences. 62: PL199-204. PMID 9570343 DOI: 10.1016/S0024-3205(98)00058-7 |
0.337 |
|
| 1997 |
Egleton RD, Davis TP. Bioavailability and transport of peptides and peptide drugs into the brain. Peptides. 18: 1431-9. PMID 9392847 DOI: 10.1016/S0196-9781(97)00242-8 |
0.835 |
|
| 1997 |
Abbruscato TJ, Thomas SA, Hruby VJ, Davis TP. Brain and spinal cord distribution of biphalin: correlation with opioid receptor density and mechanism of CNS entry. Journal of Neurochemistry. 69: 1236-45. PMID 9282948 DOI: 10.1046/J.1471-4159.1997.69031236.X |
0.424 |
|
| 1997 |
Waters SM, Davis TP. Alterations of peptide metabolism and neuropeptidase activity in senile dementia of the Alzheimer's type. Annals of the New York Academy of Sciences. 814: 30-9. PMID 9160957 DOI: 10.1111/j.1749-6632.1997.tb46142.x |
0.348 |
|
| 1997 |
Thomas SA, Abbruscato TJ, Hau VS, Gillespie TJ, Zsigo J, Hruby VJ, Davis TP. Structure-activity relationships of a series of [D-Ala2]deltorphin I and II analogues; in vitro blood-brain barrier permeability and stability. The Journal of Pharmacology and Experimental Therapeutics. 281: 817-25. PMID 9152390 |
0.774 |
|
| 1997 |
Bell IR, Schwartz GE, Bootzin RR, Hau V, Davis TP. Elevation of plasma beta-endorphin levels of shy elderly in response to novel laboratory experiences. Behavioral Medicine (Washington, D.C.). 22: 168-73. PMID 9138625 DOI: 10.1080/08964289.1997.10543550 |
0.73 |
|
| 1997 |
Waters SM, Rounseville MP, Davis TP. Effect of dopaminergic drugs on processing and degradative neuropeptidase mRNA in rat frontal cortex and caudate-putamen. Brain Research. 754: 28-34. PMID 9134956 DOI: 10.1016/S0006-8993(97)00038-3 |
0.316 |
|
| 1997 |
Abbruscato TJ, Thomas SA, Hruby VJ, Davis TP. Blood-brain barrier permeability and bioavailability of a highly potent and mu-selective opioid receptor antagonist, CTAP: comparison with morphine. The Journal of Pharmacology and Experimental Therapeutics. 280: 402-9. PMID 8996221 |
0.396 |
|
| 1996 |
Konkoy CS, Waters SM, Davis TP. Subchronic haloperidol administration decreases aminopeptidase N activity and [Met5]enkephalin metabolism in rat striatum and cortex. European Journal of Pharmacology. 297: 47-51. PMID 8851165 DOI: 10.1016/0014-2999(95)00827-6 |
0.316 |
|
| 1996 |
Rao RK, Shantaram M, Aroor AR, Raja A, Davis TP, Rao A. Molecular variants of epidermal growth factor in malignant astrocytoma. Peptides. 17: 179-81. PMID 8822528 DOI: 10.1016/0196-9781(95)02087-X |
0.333 |
|
| 1996 |
Konkoy CS, Davis TP. Ectoenzymes as sites of peptide regulation. Trends in Pharmacological Sciences. 17: 288-94. PMID 8810875 DOI: 10.1016/0165-6147(96)10036-5 |
0.334 |
|
| 1996 |
Bell IR, Bootzin RR, Davis TP, Hau V, Ritenbaugh C, Johnson KA, Schwartz GE. Time-dependent sensitization of plasma beta-endorphin in community elderly with self-reported environmental chemical odor intolerance. Biological Psychiatry. 40: 134-43. PMID 8793045 DOI: 10.1016/0006-3223(95)00331-2 |
0.729 |
|
| 1996 |
Abbruscato TJ, Williams SA, Misicka A, Lipkowski AW, Hruby VJ, Davis TP. Blood-to-central nervous system entry and stability of biphalin, a unique double-enkephalin analog, and its halogenated derivatives. The Journal of Pharmacology and Experimental Therapeutics. 276: 1049-57. PMID 8786534 |
0.394 |
|
| 1996 |
Williams SA, Abbruscato TJ, Hruby VJ, Davis TP. Passage of a delta-opioid receptor selective enkephalin, [D-penicillamine2,5] enkephalin, across the blood-brain and the blood-cerebrospinal fluid barriers. Journal of Neurochemistry. 66: 1289-99. PMID 8769896 DOI: 10.1046/J.1471-4159.1996.66031289.X |
0.428 |
|
| 1996 |
Greene DL, Hau VS, Abbruscato TJ, Bartosz H, Misicka A, Lipkowski AW, Hom S, Gillespie TJ, Hruby VJ, Davis TP. Enkephalin analog prodrugs: assessment of in vitro conversion, enzyme cleavage characterization and blood-brain barrier permeability. The Journal of Pharmacology and Experimental Therapeutics. 277: 1366-75. PMID 8667199 |
0.842 |
|
| 1995 |
Davis TP, Abbruscato TJ, Brownson E, Hruby VJ. Conformationally constrained peptide drugs targeted at the blood-brain barrier. Nida Research Monograph. 154: 47-60. PMID 8606749 |
0.365 |
|
| 1995 |
Meyer JP, Gillespie TJ, Hom S, Hruby VJ, Davis TP. In vitro stability of some reduced peptide bond pseudopeptide analogues of dynorphin A. Peptides. 16: 1215-9. PMID 8545241 DOI: 10.1016/0196-9781(95)02005-H |
0.652 |
|
| 1995 |
Konkoy CS, Davis TP. Regional metabolism of Met-enkephalin and cholecystokinin on intact ratbrain slices: characterization of specific peptidases. Journal of Neurochemistry. 65: 2773-82. PMID 7595577 DOI: 10.1046/J.1471-4159.1995.65062773.X |
0.332 |
|
| 1994 |
Polt R, Porreca F, Szabò LZ, Bilsky EJ, Davis P, Abbruscato TJ, Davis TP, Harvath R, Yamamura HI, Hruby VJ. Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier. Proceedings of the National Academy of Sciences of the United States of America. 91: 7114-8. PMID 8041755 DOI: 10.1073/Pnas.91.15.7114 |
0.504 |
|
| 1994 |
Brownson EA, Abbruscato TJ, Gillespie TJ, Hruby VJ, Davis TP. Effect of peptidases at the blood brain barrier on the permeability of enkephalin. The Journal of Pharmacology and Experimental Therapeutics. 270: 675-80. PMID 7915319 |
0.328 |
|
| 1994 |
Hruby VJ, Misicka A, Lipkowski AW, Haaseth R, Bartosz H, Qian X, Collins N, Meyer JP, Szabo L, Polt R, Porreca F, Davis T, Yamamura HI. New opioid compounds in analgesia Regulatory Peptides. 53: S71-S72. DOI: 10.1016/0167-0115(94)90246-1 |
0.304 |
|
| 1993 |
Rao RK, Koldovsky O, Davis TP. Fate of intraduodenally administered somatostatin in rats in vivo. Peptides. 14: 1199-203. PMID 7907789 DOI: 10.1016/0196-9781(93)90176-H |
0.3 |
|
| 1993 |
Konkoy CS, Oakes MG, Davis TP. Chronic treatment with neuroleptics alters neutral endopeptidase 24.11 activity in rat brain regions. Peptides. 14: 1017-20. PMID 7904340 DOI: 10.1016/0196-9781(93)90080-Z |
0.323 |
|
| 1992 |
Davis TP, Gillespie TJ, Konings PN. Specificity of neurotensin metabolism by regional rat brain slices. Journal of Neurochemistry. 58: 608-17. PMID 1729405 DOI: 10.1111/J.1471-4159.1992.Tb09762.X |
0.417 |
|
| 1992 |
Banks WA, Audus KL, Davis TP. Permeability of the blood-brain barrier to peptides: an approach to the development of therapeutically useful analogs. Peptides. 13: 1289-94. PMID 1494505 DOI: 10.1016/0196-9781(92)90037-4 |
0.428 |
|
| 1992 |
Weber SJ, Greene DL, Hruby VJ, Yamamura HI, Porreca F, Davis TP. Whole body and brain distribution of [3H]cyclic [D-Pen2,D-Pen5] enkephalin after intraperitoneal, intravenous, oral and subcutaneous administration. The Journal of Pharmacology and Experimental Therapeutics. 263: 1308-16. PMID 1469637 |
0.349 |
|
| 1992 |
Gillespie TJ, Konings PN, Merrill BJ, Davis TP. A specific enzyme assay for aminopeptidase M in rat brain. Life Sciences. 51: 2097-106. PMID 1361957 DOI: 10.1016/0024-3205(92)90161-H |
0.381 |
|
| 1992 |
Weber SJ, Louis RB, Trombley L, Bissette G, Davies P, Davis TP. Metabolic half-life of somatostatin and peptidase activities are altered in Alzheimer's disease. Journal of Gerontology. 47: B18-25. PMID 1346149 DOI: 10.1093/Geronj/47.1.B18 |
0.31 |
|
| 1991 |
Davis TP, Gillespie TJ, Shook J, Kramer TH, Hoyer G, Hawkins K, Davis P, Yamamura HI, Burks TF. Changes in opioid receptor selectivity following processing of peptide E: effect on gut motility. Gastroenterology. 100: 1603-15. PMID 1850373 DOI: 10.1016/0016-5085(91)90659-9 |
0.318 |
|
| 1991 |
Davis TP, Crowell S, McInturff B, Louis R, Gillespie T. Neurotensin may function as a regulatory peptide in small cell lung cancer. Peptides. 12: 17-23. PMID 1646999 DOI: 10.1016/0196-9781(91)90160-Q |
0.31 |
|
| 1990 |
Li ZW, Bijl WA, van Nispen JW, Brendel K, Davis TP. Neuropeptide processing in regional brain slices: effect of conformation and sequence. The Journal of Pharmacology and Experimental Therapeutics. 253: 851-7. PMID 2140132 |
0.302 |
|
| 1990 |
Davis TP, Hoyer GL, Davis P, Burks TF. Proenkephalin A-derived peptide E and its fragments alter opioid contractility in the small intestine. European Journal of Pharmacology. 191: 253-61. PMID 2086244 DOI: 10.1016/0014-2999(90)94157-S |
0.319 |
|
| 1989 |
Davis TP, Gillespie TJ, Porreca F. Peptide fragments derived from the beta-chain of hemoglobin (hemorphins) are centrally active in vivo. Peptides. 10: 747-51. PMID 2587417 DOI: 10.1016/0196-9781(89)90107-1 |
0.337 |
|
| 1986 |
Davis TP, Culling-Berglund AJ, Schoemaker H. Specific regional differences of in vitro beta-endorphin metabolism in schizophrenics. Life Sciences. 39: 2601-9. PMID 2948088 DOI: 10.1016/0024-3205(86)90115-3 |
0.311 |
|
| 1985 |
Davis TP, Porreca F, Burks TF, Dray A. The proenkephalin A fragment, peptide E: central processing and CNS activity in vivo. European Journal of Pharmacology. 111: 177-83. PMID 2990950 DOI: 10.1016/0014-2999(85)90754-X |
0.326 |
|
| 1985 |
Davis TP, Culling-Berglund A. High-performance liquid chromatographic analysis of in vitro central neuropeptide processing. Journal of Chromatography. 327: 279-92. PMID 2411750 DOI: 10.1016/S0021-9673(01)81657-5 |
0.395 |
|
| 1984 |
Dray A, Metsch R, Davis TP. Endorphins and the central inhibition of urinary bladder motility. Peptides. 5: 645-7. PMID 6206486 DOI: 10.1016/0196-9781(84)90097-4 |
0.311 |
|
| 1984 |
Brinton RE, Gee KW, Wamsley JK, Davis TP, Yamamura HI. Regional distribution of putative vasopressin receptors in rat brain and pituitary by quantitative autoradiography. Proceedings of the National Academy of Sciences of the United States of America. 81: 7248-52. PMID 6095279 DOI: 10.1073/Pnas.81.22.7248 |
0.328 |
|
| 1984 |
Schoemaker H, Davis TP. Differential in vitro metabolism of beta-endorphin in schizophrenia. Peptides. 5: 1049-54. PMID 6085162 DOI: 10.1016/0196-9781(84)90169-4 |
0.337 |
|
| 1984 |
Davis TP, Schoemaker H, Culling-Berglund AJ. Characterization of in vitro proteolytic processing of beta-endorphin by reversed-phase HPLC. Peptides. 5: 1037-42. PMID 6085161 DOI: 10.1016/0196-9781(84)90167-0 |
0.314 |
|
| 1983 |
Brinton RE, Deshmukh PP, Chen A, Davis TP, Hsiao S, Yamamura HI. A non-equilibrium 24-hour vasopressin radioimmunoassay: development and basal levels in the rat brain. Brain Research. 266: 344-7. PMID 6871669 DOI: 10.1016/0006-8993(83)90667-4 |
0.405 |
|
| 1983 |
Yamamura HI, Gee KW, Brinton RE, Davis TP, Hadley M, Wamsley JK. Light microscopic autoradiographic visualization of [3H]-arginine vasopressin binding sites in rat brain. Life Sciences. 32: 1919-24. PMID 6300592 DOI: 10.1016/0024-3205(83)90072-3 |
0.323 |
|
| 1982 |
Davis TP, Schoemaker H, Chen A, Yamamura HI. I. High performance liquid chromatography of pharmacologically active amines and peptides in biological materials Life Sciences. 30: 971-987. PMID 6280002 DOI: 10.1016/0024-3205(82)90515-X |
0.388 |
|
| 1982 |
Schoemaker H, Davis TP, Pedigo NW, Chen A, Berens ES, Ragan P, Ling NC, Yamamura HI. Identification of beta-endorphin-6(16-17) as the principal metabolite of des-tyrosin-gamma-endorphin (DTgammaE) in vitro and assessment of its activity in neurotransmitter receptor binding assays. European Journal of Pharmacology. 81: 459-68. PMID 6126374 DOI: 10.1016/0014-2999(82)90111-X |
0.315 |
|
| 1978 |
Davis TP, Gehrke CW, Gehrke CW, Cunningham TD, Kuo KC, Gerhardt KO, Johnson HD, Williams CH. High-performance liquid-chromatographic separation and fluorescence measurement of biogenic amines in plasma, urine, and tissue. Clinical Chemistry. 24: 1317-1324. DOI: 10.1093/CLINCHEM/24.8.1317 |
0.317 |
|
| Show low-probability matches. |